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Abstract Hydrazide ligand, (Z)-N’-(6-oxo-1,10-
phenanthrolin-5(6H)-ylidene)isonicotinohydrazide, 1
forms from a 1:1 Schiff base condensation reaction
between isoniazid (INH) and 1,10-phenanthroline-
5,6-dione (phendione). Ag? and Mn2? complexes
with 1:2 metal:ligand stoichiometry are prepared:
[Ag(1)2]NO3, [Ag(1)2]BF4 and [Mn(1)2](NO3)2. Poly-
meric {[Ag(1)(NO3)]}n has 1:1 stoichiometry and
forms upon infusion of CH2Cl2 into a DMSO solution
of [Ag(1)2]NO3. {[Ag(1)(NO3)]}n was structurally
characterized using X-ray crystallography. Metal-free
1 and its 1:2 complexes exhibit very good, broad-
spectrum antimicrobial activity and are not exces-
sively toxic to mammalian cells (A549 lineage).
Keywords 1,10-Phenanthroline  Metal complexes 
Antibacterial activity  Antibiotic resistance  Anti-
tuberculosis activity
Introduction
Pathogenic bacteria, fungi, parasites and viruses can
trigger sepsis, a condition whereby the body’s
response to infection induces tissue and organ dys-
function, leading to excessive morbidity and mortal-
ity. In both community and clinic settings septicaemia
is estimated to affect over 30 million people annually
and causes up to 6 million fatalities (WHO factsheet
2018). The World Health Assembly (WHA) (Seventh
WHA 2018) and the World Health Organization
(WHO) (WHO factsheet 2018) both acknowledge that
more investment is required for research into finding
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Institute Paulo de Góes, Federal University of Rio de
Janeiro, Rio de Janeiro, Brazil
M. C. Lourenço  K. Gomes
Bacteriology Laboratory, Evandro Chagas Clinical
Research Institute, Oswaldo Cruz Foundation,




new and cost-effective antimicrobials to overcome the
major problem of drug resistance.
Since the 1950s, metal-free ligands and coordina-
tion complexes constituted by members of the 1,10-
phenanthroline family of N,N’-chelating ligands have
been shown to inhibit the growth of potentially
harmful microorganisms (MacLeod 1952; Dwyer
et al. 1957, 1969a, b; Shulman and Dwyer 1964;
Butler et al. 1969, 1970; Cade et al. 1970; McCann
et al. 2012a, b; Viganor et al. 2017; McCarron et al.
2018). Dwyer et al. (1969a, b) formulated and patented
phenanthroline-containing therapeutics for topical
application to humans, lower animals and plants in
order to combat diseases induced by a wide variety of
organisms. In 1970 in Melbourne, Australia, the
results of two controlled clinical trials (Cade et al.
1970; Bulter et al. 1970) on patients suffering from
topical infections due to fungi, bacteria and protozoa
showed the highly beneficial effects of the topical
application of formulations containing Mn2?, Cu2?
and Ni2? complexes of 3,4,7,8-tetramethyl-1,10-
phenanthroline. Additionally, the metal complexes
were non-toxic and it was reported in the trial
involving the Mn2? complexes (Cade et al. 1970) that
microbial resistance did not develop.
In the current paper, we outline the synthesis of a
new Schiff base ligand, 1, derived by reacting the anti-
tuberculosis drug, isoniazid (INH), with 1,10-phenan-
throline-5,6-dione (phendione) (Scheme 1). Ag? and
Mn2? complexes of 1 were also prepared and one of
the Ag? species was structurally characterised. Also
presented are the results of in vitro growth inhibition
tests against bacterial (Mycobacterium tuberculosis,
Staphylococcus aureus and Pseudomonas aeruginosa)
and fungal (Candida albicans) pathogens. Addition-
ally, the cytotoxicity of 1 and its complexes towards
lung epithelial A549 cells was assessed and selectivity
index (SI) values established.
Materials and methods
All reagents used in chemical syntheses were com-
mercially available (Sigma-Aldrich) and were used as
supplied. Phendione was synthesised using a literature
procedure (Zheng et al. 2010). All experiments
involving Ag? compounds were conducted in the
absence of light and samples were stored in the dark.
NMR (Nuclear Magnetic Resonance) spectra were
recorded on a Bruker Avance spectrometer operating
at 500 MHz for 1H nucleus and 125 MHz for the 13C
nucleus. The probe temperature was maintained at
25 C. Electrospray ionization (ESI) High Resolution
Mass Spectrometry (HRMS) analyses were collected
on an Agilent-L 1200 Series coupled to a 6210 Agilent
Time-of-Flight (TOF) equipped with both a positive
and negative electrospray source.
Infrared spectra were recorded as KBr discs in the
region 4000–400 cm-1 on a Perkin-Elmer 100 series
spectrometer. Elemental analyses (%CHN) were car-
ried out using a FLASH EA 1112 Series Elemental
Analyser with Eager 300 operating software. Mag-
netic moment measurements were taken at room
temperature using a Johnson Matthey Magnetic Sus-
ceptibility Balance with Hg[Co(SCN)4] being used as
the calibration standard.
X-ray structural analysis for crystals of
{[Ag(1)(NO3)]}n (Table 1) were performed on a
Bruker APEX Duo CCD at 100(2) K with an Oxford
Cobra cryostat, with the sample mounted on a
MiTeGen microloop using Mo Ka radiation
(k = 0.71073 Å). Bruker APEX (Bruker 2015) soft-
ware was used to collect and reduce data and
determine the space group. Absorption corrections
were applied using SADABS (Bruker 2014–2015).
Structures were solved with the XT structure solution
program (Sheldrick 2015) using Intrinsic Phasing and
refined with the XL refinement package (Sheldrick
Scheme 1 Synthesis of
ligand 1
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2008) using Least Squares minimisation in Olex2
(Dolomanov et al. 2009). All non-hydrogen atoms
were refined anisotropically. Hydrogen atoms were
assigned to calculated positions using a riding model
with appropriately fixed isotropic thermal parameters.





1,10-Phenanthroline-5,6-dione (phendione) (0.210 g,
1.000 mmol) was added to solution of isonicotinic
acid hydrazide (isoniazid, (INH)) (0.137 g,
1.000 mmol) in EtOH (25 cm3). p-Toluenesulfonic
acid (10%, 0.02 g, 0.10 mmol) was added and the
solution refluxed for 6 h. The resulting suspension was
filtered whilst hot to remove a very small quantity of
precipitated 1,10-phenanthroline-5,6-diol. The bright
orange filtrate was allowed to stand in the dark
overnight. Yellow needles of 1 were filtered off,
washed with EtOH (3 9 10 cm3) and air-dried.
Yield: 0.263 g, 79%. MP: 210–211 C.
Calculated (C18H11N5O20.5H2O): C, 63.90; H,
3.58; N, 20.70%. Found: C, 63.84; H, 3.39; N, 20.78%.
HRMS: calculated m/z for C18H11N5O2: (M ? H)
?
330.0986. Found: (M ? H)? 330.0997.
IR (KBr, cm-1): 3424 [w. br], 3047.77 [w. br] 1723
[s. sh], 1635 [s. sh], 1576 [w. sh], 1557 [w. sh], 1509 [s.



















q (calc. Mg/m3) 1.955
l (mm-1) 1.239
F(000) 496
Crystal size (mm3) 0.13 9 0.12 9 0.05
Theta range for data collection () 2.039 to 27.186
Reflections collected 11367
Independent reflections 3790 [R(int) = 0.0621]
Max. and min. transmission 0.7455 and 0.6472
Data/restraints/parameters 3790/1/275
Goodness-of-fit on F2 1.025
Final R indices [I[ 2r(I)] R1 = 0.0419, wR2 = 0.0659
R indices (all data R1 = 0.0685, wR2 = 0.0719
Largest diff. peak and hole (e Å-3) 0.533 and - 0.875
CCDC No. 1907353
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br], 1445 [w], 1407 [m], 1223 [s. sh], 1180 [s. sh],
1064 [s. sh], 1011 [s. sh], 752 [m. sh], 686 [m. sh].
1H NMR (d6-DMSO, 500 MHz): d 15.13 (s, 1H, O–
HN), 9.11 (dd, J = 4.5, 1.7 Hz, 1H, PhenH), 8.94 (dd,
J = 4.4, 1.6 Hz, 2H, PyH), 8.90 (dd, J = 4.5, 1.7 Hz,
1H, PhenH), 8.61 (dd, J = 7.9, 1.7 Hz, 1H, PhenH),
8.50 (d, J = 7.9 Hz, 1H, PhenH), 7.88 (dd, J = 4.4,
1.6 Hz, 2H, PyH), 7.75 (dd, J = 7.9, 4.5 Hz, 1H,
PhenH), 7.67 (dd, J = 7.9, 4.5 Hz, 1H, PhenH).
13C NMR (d6-DMSO, 125 MHz): d 181.9
(PhenC=O), 164.5 (C=O), 156.2 (PhenC), 152.7
(PhenC), 151.6 (PhenC), 151.4(PyrC), 147.1 (PhenC),
139.4 (PyrC), 136.3 (PhenC), 135.1 (PhenC), 132.2
(PhenC), 128.6 (PhenC), 127.8 (PhenC), 125.6
(PhenC), 125.3 (PhenC), 122.0 (PyrC).
[Ag(1)2]NO3 and [Ag(1)2]BF4
A solution of AgNO3 or AgBF4 (0.085 g or 0.097 g,
respectively, 0.500 mmol) in MeCN (20 cm3) was
added to a warm solution of 1 (0.329 g, 1.00 mmol) in
MeCN (80 cm3). The resulting suspension was
refluxed for 3 h and filtered whilst hot to give an
orange/yellow solid. The solid was washed with hot
MeCN (3 9 20 cm3) and then with hot DCM
(5 9 20 cm3), and dried under vacuum.
[Ag(1)2]NO32H2O yield: 0.316 g, 76%.
Calculated [Ag(C18H11N5O2)2]NO32H2O: C,
50.01; H,3.03; N, 17.82%. Found: C, 50.44; H, 2.79;
N, 17.91%.
MS: calculated m/z for [Ag(C18H11N5O2)2]
?: (M)?
765.0876. Found: (M)? 765.0873.
IR (KBr, cm-1): 3412 [w. br], 3078 [w. br], 1712 [s.
sh], 1631 [s. sh], 1578 [w. sh], 1564 [w. sh], 1510 [s.
br], 1455 [w], 1409 [m], 1340 [s. br], 1217 [s. sh], 1187
[s. sh], 1068 [s. sh], 1048 [m. sh], 1020 [s. sh], 844 [w.
sh], 830 [w. sh], 749 [w. sh], 679 [m. sh], 633 [w. sh].
1H NMR (d6-DMSO, 500 MHz): d 15.15 (s, 2H, O–
HN), 9.14 (dd, J = 4.8, 1.7 Hz, 2H, PhenH), 8.97-8.93
(m, 6H, 2PhenH & 4PyH), 8.84 (dd, J = 8.0, 1.7 Hz,
2H, PhenH), 8.73 (d, J = 8.0 Hz, 2H, PhenH), 7.98
(dd, J = 8.0, 4.8 Hz, 2H, PhenH), 7.93-7.90 (m, 6H,
2PhenH & 4PyH).
13C NMR (d6-DMSO, 125 MHz): d 180.9
(PhenC = O), 164.5 (C = O), 156.4 (PhenC), 152.2
(PhenC), 151.5 (PyrC), 149.6 (PhenC), 144.1
(PhenC), 139.3 (PyrC), 137.9 (PhenC), 134.7
(PhenC), 134.0 (PhenC), 130.1 (PhenC), 128.9
(PhenC), 127.3 (PhenC), 126.9 (PhenC), 122.1
(PyrC).
[Ag(1)2]BF4 Yield: 0.305 g, 72%.
Calculated [Ag(C18H11N5O2)2]BF4: C, 50.67; H,
2.60; N, 16.41%. Found: C, 50.02; H, 2.24; N, 16.06%.
MS: Calculated m/z for [Ag(C18H11N5O2)2]
?:
(M)? 765.0876. Found: (M)? 765.0908;
IR (KBr, cm-1): 3402 [w. br], 3101 [w. br], 1706 [s.
sh], 1629 [m. sh], 1580 [w. sh], 1564 [w. sh], 1521 [s.
br], 1458 [w], 1409 [s, sh], 1290 [w. sh], 1228 [m. sh],
1185 [m. sh], 1080–1030 [s. br v(BF4)], 1021 [s. sh],
846 [w. sh], 816 [w. sh], 747 [w. sh], 681 [m. sh], 631
[w. sh].
1H NMR (d6-DMSO, 500 MHz): d 15.14 (s, 2H, O–
HN), 9.13 (dd, J = 4.8, 1.7 Hz, 1H, 2PhenH),
8.95–8.92 (m, 6H, 2PhenH & 4PyH), 8.82 (dd,
J = 8.0, 1.7 Hz, 2H, PhenH), 8.70 (d, J = 8.0 Hz,
2H, PhenH), 7.97 (dd, J = 8.0, 4.8 Hz, 2H, PhenH),
7.94–7.83 (m, 6H, 2PhenH & 4PyH).
13C NMR (d6-DMSO, 125 MHz): d 180.5
(PhenC=O), 164.5 (C=O), 156.0 (PhenC), 151.8
(PhenC), 151.1 (PyrC), 149.2 (PhenC), 143.6
(PhenC), 138.8 (PyrC), 137.5 (PhenC), 134.2
(PhenCN), 133.5 (PhenC), 129.6 (PhenC), 128.3
(PhenC), 126.9 (PhenC), 126.5 (PhenC), 121.6
(PyrC).
Slow diffusion of DCM vapour into a saturated
DMSO solution of [Ag(1)2]NO32H2O over a period
of 9 months resulted in the formation of yellow
crystals of {[Ag(1)(NO3)]}n which were suitable for
X-ray crystallographic analysis.
[Mn(1)2](NO3)22H2O
A solution of Mn(NO3)24H2O (0.126 g, 0.500 mmol)
in MeCN (20 cm3) was added to a warm solution of 1
(0.329 g, 1.000 mmol) in MeCN (80 cm3) and the
bright yellow suspension refluxed for 3 h. The mixture
was filtered whilst hot and the orange solid washed
with hot MeCN (3 9 20 cm3) and then hot dichlor-
omethane (5 9 20 cm3), and dried under vacuum.
Yield: 0.310 g, 70%.
Calculated [Mn(C18H11N5O2)2](NO3)22H2O: C,
49.50; H, 3.00; N, 19.24%. Found: C, 49.67; H,
2.45; N, 19.02%.
IR (KBr, cm-1): 3422 [w. br], 3091 [w. br], 1719 [s.
sh], 1642 [s. sh], 1575 [m. sh], 1520 [s. br], 1443 [s.
br], 1421 [s. sh], 1385 [s. sh], 1303 [s. br], 1265 [m.
sh], 1225 [s. sh], 1186 [m. sh], 1071 [m. sh], 1020 [s.
123
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sh], 844 [w. sh], 819 [w. sh], 748 [m. sh], 682 [m. sh],
639 [w. sh].
leff = 6.2 B.M.
Biological testing
Antibacterial activity
The antibacterial susceptibility profiles of Gram-
positive S. aureus (ATCC 25923) and Gram-negative
P. aeruginosa (ATCC 27853) were determined
according to the protocol recommended by the Clin-
ical and Laboratory Standards Institute (CLSI) (CLSI
2012a, b) using a 96-well microtiter plate with
Mueller–Hinton broth (MHB) containing different
concentrations of each test compound (starting from a
20 mM solution in DMSO) and classical antibacterial
agents (ciprofloxacin and ceftazidime). The lowest
concentration of each compound that inhibited bacte-
rial growth, as ascertained by the absence of visible
turbidity in each well, was considered to be the MIC
value.
Anti-mycobacterial activity
Activities of the test compounds as well as isoniazid
were assessed against M. tuberculosis H37Rv (ATCC
27294) using the microplate Alamar Blue Assay
(Accumed International, Westlake, OH, USA) (Franz-
blau et al. 1998). This methodology is nontoxic, uses a
thermally-stable reagent and shows good correlation
with proportional and BACTEC radiometric methods
(Tortoli et al. 2002; Kontos et al. 2004). Mycobacteria
were grown in Middlebrook 7H9 medium (Becton–
Dickinson, Sparks, MD, USA) supplemented with
10% oleic acid-albumin-dextrose-catalase (OADC)
and 0.05% Tween 80 and on Middlebrook 7H10 solid
agar medium (Becton–Dickinson) supplemented with
10% OADC. The MICs were determined as described
previously (Franzblau et al. 1998). Briefly, all
mycobacterial strains were prepared from scoops of
solid culture and suspended in PBS plus Tween 80, to
reach a concentration equivalent to McFarland Stan-
dard No. 1 (approximately 3 9 107 colony-forming
units (CFU)/mL) and then diluted in Middlebrook 7H9
medium supplemented with 10% OADC to about 105
CFU/mL. One hundred microliters of the bacterial
suspensions were added to microtiter plates contain-
ing, in each well, twofold diluted drugs in 100 lL of
Middlebrook 7H9 medium with 10% OADC. The
volume of drug-free and mycobacteria-free wells was
adjusted to 200 lL and used as the control. The plates
were incubated at 37 C for 5 days. Twenty micro-
liters of Alamar Blue dye and 12.5 lL of 20%
sterilized Tween 80 reagent were added. The plates
were re-incubated at 37 C for 24 h, and the colors of
all wells were recorded. The MIC was defined as the
lowest drug concentration that prevented a color
change from blue to pink.
Antifungal activity
Antifungal susceptibility testing was performed using
Candida albicans (ATCC 36802) according to the
standardized broth microdilution technique described
by the CLSI (CLSI 2008) and was interpreted
according to the CLSI published document (CLSI
2012a, b). The test compounds and the clinical
antifungal drug, amphotericin B, were evaluated and
the MICs were determined by visual inspection
following incubation in a humid atmosphere at
35 C for 48 h.
Cytotoxicity assay
The effects of the test compounds on the viability of
A549 cells (ATCC CCL-185, alveolar basal epithelial
cell of human adenocarcinoma) was evaluated using
the MTT assay (Mosmann 1983). First, the A549 cells
were allowed to adhere in 96-well tissue culture plates,
and then the cells were treated with increasing
concentrations of the compounds and incubated up
to 48 h at 37 C in a 5% CO2 atmosphere. Subse-
quently, the culture medium was discarded and the
formation of formazan crystals was measured by
adding MTT (5 mg/mL in PBS, 25 lg/mL) and
incubating the wells for an additional 3 h in the dark
at 37 C. The plates were centrifuged at 5009g for
10 min, the supernatant removed, the pellet dissolved
in 200 lL of DMSO and the absorbance measured in
an ELISA reader at 570 nm (SpectraMax Gemini 190,
Molecular Devices, CA, USA). The 50% cytotoxicity
inhibitory concentration (CC50) was determined by
linear regression analysis.
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Results and discussion
Chemical synthesis
The hydrazide ligand 1 was prepared in good yield
using a Schiff base condensation reaction between
INH and phendione under acidic conditions. Although
our initial aim was to carry out a Schiff base reaction at
both carbonyl groups of phendione (by treatment with
two equivalents of INH) only the mono Schiff base
hydrazide formed. Even in the presence of a large
excess INH (up to four equivalents) the double Schiff
base adduct was not isolated. In this context, our group
has previously reported that not all intended double
Schiff base reactions proceed as anticipated upon
reaction of phendione with amines. For example,
chiral, multi-ring products formed upon reaction of
phendione with N,N’-bis(2-aminophenyl)ethylenedi-
amine (Coyle et al. 2003) and diethylenetriamine (Lin
et al. 2006). Also, combining phendione with urea
produced bipyridine-glycoluril (Elmans et al. 1998)
whilst the reaction with L-tyrosine methyl ester gave a
novel phenanthroline-oxazine (McCann et al. 2013).
Whereas the IR spectrum of phendione contains a
m(C=O) band at 1685 cm-1 the spectrum of 1 has the
carbonyl stretching band at 1723 cm-1 and an imine
C=N stretch at 1635 cm-1 (Supplementary Material).
The 1H NMR spectrum of 1 (d6-DMSO) (Supplemen-
tary material) showed an uncharacteristic downfield
resonance for the amide H atom at 15.08 ppm,
suggesting that H-bonding is taking place between it
and the O atom of the ketone group on the backbone of
the phendione moiety. H-bonding of this type has
previously been documented for hydrazones of similar
structure and it leads to keto-enol tautomerization
(Benković et al. 2018; Cheon et al. 2002; Barbazán
et al. 2010). The 1H NMR spectrum of 1 in d4-
methanol shows additional peaks in the region
7.5–9.1 ppm compared to that recorded in d6-DMSO,
indicating that the tautomerization process is more
clearly observed in the former solvent. It is believed
that it is the presence of the intramolecular H-bonding
between the NH moiety of the hydrazone and ketone
oxygen atom which causes the carbonyl carbon to be
less electrophilic and thus decreases the susceptibility
of this carbonyl group toward further Schiff base
(imine) formation. Imine functionalities are well
known to undergo hydrolysis back to starting materials
(Yildiz 2016; Buss and Ponka 2003). Thus, the
stability of 1 towards hydrolysis was investigated by
monitoring changes in the 1H NMR spectrum of a
solution of the compound in d6-DMSO upon addition
of a few drops of D2O. No spectral changes were
observed over a period of 1 week at ambient temper-
ature indicating the relative stability of the C=N
moiety towards hydrolysis. The structure of 1 is
expected to be essentially identical to that of the
closely related hydrazones formed by reacting phen-
dione with benzoic acid hydrazide and 2-hydroxyben-
zoic acid hydrazide (Barbazán et al. 2010).
Metal complexes of 1 were synthesised by reacting
simple Ag? and Mn2? tetrafluoroborate or nitrate salts
with ligand 1 in a metal ion:ligand ratio of 1:2. The
resulting complexes formulated as [Ag(1)2]NO3,
[Ag(1)2]BF4 and [Mn(1)2](NO3)2. The IR spectra of
the complexes contained bands associated with ligand
1 and the NO3
-/BF4
- anions (Supplementary mate-
rial). The mass spectra of the Ag? complexes showed
peaks for the [Ag(1)2]
? ion with characteristic isotopic
patterns (Supplementary Material). Small shifts of the
signals for the phenanthroline protons are seen when
the 1H NMR spectrum (d4-methanol) of the free ligand
is compared to those of the Ag? complexes. It is
anticipated that in the core structure of the Ag? and
Mn2? complexes the metal ion is chelated by both
nitrogen atoms from the phendione moiety of each
molecule of 1, as has been shown previously in the
cases of [Ag(phendione)2]ClO4 (McCann et al. 2004),
[Ag(phendione)(CH3CO2)]3H2O (Oneugbu et al.
2008) and [Cu(phendione)3](ClO4)22H2O2MeCN
(Liu et al. 2000). Intermolecular coordination by the
pyridine N atom of the INH moiety of 1 is also
possible.
Interestingly, when the 1H NMR spectrum of
[Ag(1)2]NO32H2O was recorded in d6-DMSO new
peaks appeared over a period of 3 days (Supplemen-
tary Material), the solution colour darkened visibly
and precipitation was observed. These effects
occurred both in the presence and in the absence of
light but were not seen with the [Ag(1)2]BF4 sample
(NMR spectrum remained unchanged and the solution
did not darken in the presence of light). Furthermore,
slow diffusion of DCM vapour into a saturated DMSO
solution of [Ag(1)2]NO32H2O over a prolonged
period resulted in the formation of a new complex
which X-ray crystallographic analysis revealed it to be
polymeric and formulating with the 1:1 metal:ligand
stoichiometry, {[Ag(1)(NO3)]}n (Figs. 1, 2, 3;
123
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Table 2). In this complex, ligand 1 is seen to be
ambidentate. Each Ag? ion is bonded to three
heterocyclic nitrogen atoms with the shortest Ag–N
distance to the pyridine N atom of the INH moiety
(Ag1–N1; 2.225(3) Å) and there are longer bonds to
the N,N’ chelating atoms of the phendione moiety of
the adjacent ligand molecule (Ag1–N16i and Ag1–
N19i; 2.434(3) and 2.314(3) Å, respectively;
i = equivalent atom symmetry generation transforma-
tion x - 1, y ? 1, z - 1). The chelating phendione
moiety creates the narrowest N–Ag–N angle (N19i–
Ag1–N16i; 70.24(10)), whilst N1–Ag1–N16i is
118.56(10). The N1–Ag1–N19i angle of
163.08(10) is closest to being linear. The nitrate
anion chelates to the central Ag? ion (Ag–O28;
2.6468(28) and Ag–O27; 2.7822(27) Å), and it also
serves to link the polymeric planes via extensive
hydrogen bonding (Fig. 3). Finally, there is an
intramolecular hydrogen bond within ligand 1 involv-
ing the hydrogen attached to N9 of the INH moiety and
the carbonyl oxygen (O25) of the phendione moiety
(Figs. 1, 2). The existence of such an intramolecular
hydrogen bond within the metal-free ligand 1 was










used to generate equivalent
atoms i = x - 1, y ? 1,
z - 1) chain for
{[Ag(1)(NO3)]}n with
intramolecular hydrogen
bonding showing the Ag?
coordination by the nitrate
anion
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inferred earlier from the 1H NMR spectral studies of
metal-free 1.
Biological studies
The results of the biological screening studies for the
metal-free ligand, 1, the Ag? and Mn2? complexes of
1, metal-free 1,10-phenanthroline, simple metal salts
and some clinically used drugs are compiled in
Tables 3 and 4.
Anti-M. tuberculosis activity
In terms of lM concentrations, the metal-free ligands,
1 and 1,10-phenanthroline, showed very similar
activities against M. tuberculosis strain H37RV
(Table 3), suggesting that the INH moiety of 1 is not
playing a dominant role in inhibiting the growth of this
bacterium. Furthermore, these two metal-free ligands
were only marginally less effective than the prescribed
drug, isoniazid. Whilst the simple metal salts, AgBF4
and Mn(NO3)24H2O, displayed only marginal (Ag?)
to poor (Mn2?) activities, the metal complexes of 1,
[Ag(1)2]BF4, [Ag(1)2]NO32H2O and [Mn(1)2](-
NO3)22H2O, were almost fourfold more potent than
isoniazid. Interestingly, there was no real variation in
activity across the three members of the group of metal
complexes of 1, suggesting that activity was indepen-
dent of the type of chelated central metal ion (Ag? or
Mn2?). This is in stark contrast to the trend observed
with the simple metal salts where the performance of
AgBF4 was over 11-fold superior to Mn(NO3)24H2O.
It was also evident that the potencies of the three metal
complexes of 1 were significantly better than the
combined activities of metal-free 1 and its respective
simple metal salt, implying that dispensing the com-
plex as a discrete entity was appreciably more
beneficial than the additive effect of administering
separate units of metal-free 1 along with the simple
metal salt.
Encouragingly, preliminary tests involving three
different rifampicin- and isoniazid-resistant M. tuber-
culosis strains (665/0514, SR Cult 84/17 and SR
3.11 Å
2.76 Å
Fig. 3 Lamellar arrangement of {[Ag(1)2(NO3)]}n viewed
normal to the b-axis. The average distances between the planes
described by the atoms in the ligand are ca. (a) 3.11 Å between
the two planes incorporating the nitrate anion via hydrogen
bonding and (b) 2.76 Å separating these hydrogen bonded
dimeric planes















Symmetry transformations used to generate equivalent atoms:
i = x - 1, y ? 1, z - 1
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2571/0215) have revealed that 1 and its Ag? and Mn2?
complexes greatly impede the growth of these highly
resilient bacteria as similarly detected against the
sensitive strain, H37RV (data not shown).
Anti-S. aureus and P. aeruginosa activity
Metal-free 1 and its metal complexes were up to
sixfold less active against Gram-positive S. aureus in
comparison toM. tuberculosis (Table 3). In contrast to
the observation of the similar activities of metal-free 1
and metal-free 1,10-phenanthroline towards M.
tuberculosis, the latter ligand was ca. 60-fold less
potent than 1 against S. aureus, implying that the INH
moiety of 1 is exerting a very influential and positive
effect on its activity against this bacterium.
S. aureus was more sensitive to AgBF4 and
Mn(NO3)24H2O than M. tuberculosis, with the Ag?
simple salt being the most effective. [Ag(1)2]BF4,
[Ag(1)2]NO32H2O and [Mn(1)2](NO3)22H2O had
activities similar to those of the clinical drugs,
ciprofloxacin and ceftazidime, the remaining com-
pounds being much less effective.
Table 3 Effects of test compounds on some clinically relevant microorganisms
Compounds MIC (lg/ml (lM))








1 5 (15.18) 16 (48.59) 128 (388.69) 4 (12.15)
[Ag(1)2]BF4 2.5 (2.93) 8 (9.38) 8 (9.38) 2 (2.34)
[Ag(1)2]NO32H2O 2.5 (2.89) 16 (18.51) 8 (9.25) 2 (2.31)
[Mn(1)2](NO3)22H2O 2.5 (2.99) 16 (19.10) 512 (611.29) 16 (19.10)
AgBF4 10 (51.36) 4 (20.54) 2 (10.27) 0.25 (1.29)
Mn(NO3)24H2O [ 100 ([ 558.82) 64 (355.14) 64 (355.14) [ 512 ([ 2861.13)
1,10-Phenanthroline 2.5 (13.87) [ 512 ([ 2861.13) [ 512 ([ 2861.13) 0.25 (1.39)
Isoniazid 1.56 (11.38) ND ND ND
Amphotericin B ND ND ND 0.06 (0.06)
Ciprofloxacin ND 4 (12.07) 4 (12.07) ND
Ceftazidime ND 16 (29.28) 4 (7.32) ND
ND non-determined
aRifampicin- and isoniazid-sensitive strain
Table 4 Toxicity of test compounds on A549 epithelial cells and selectivity index (SI) values for the test microorganisms













1 157.23 10.36 3.24 0.40 12.94
[Ag(1)2]BF4 44.11 15.05 4.70 4.70 18.85
[Ag(1)2]NO32H2O 48.47 16.76 2.62 5.24 21.01
[Mn(1)2](NO3)22H2O 56.67 18.95 2.97 0.09 2.97
AgBF4 95.53 1.86 4.65 9.30 74.05
1,10-Phenanthroline 2422.29 174.64 6.82 6.82 1742.65
Isoniazid 3500.10 307.57 ND ND ND
Amphotericin B 8.59 ND ND ND 143.17
ND non-determined
aSI = CC50 value/MIC value
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Metal-free 1 and [Mn(1)2](NO3)22H2O were
notably much less effective towards Gram-negative
P. aeruginosa than against M. tuberculosis and Gram-
positive S. aureus. Only [Ag(1)2]BF4 and [Ag(1)2]-
NO32H2O had efficiencies approaching those of
ciprofloxacin and ceftazidime towards P. aeruginosa.
Anti-C. albicans activity
With the exception of the Mn2? simple salt,
Mn(NO3)24H2O, all of the test compounds were very
active against the fungus, C. albicans. Although the
compounds were much less effective than the clinical
drug, amphotericin B (MIC 0.06 lM), the latter
polyene is reputed to have severe nephrotoxicity
associated with it which often prompts a discontinu-
ation of therapy despite a life-threatening, systemic
fungal infection (Sabra and Branch 1990).
Toxicity versus A549 cell line
Mammalian A549 cells were the least sensitive to
metal-free isoniazid, followed by metal-free 1,10-
phenanthroline (Table 4). In comparison, metal-free
1, which is a molecule whose framework is essentially
a fusion of isoniazid with 1,10-phenanthroline, was
much less well tolerated by the A549 cells. The Ag?
and Mn2? complexes of 1 were ca. threefold more
toxic towards these cells than metal-free 1. Ampho-
tericin B had the most detrimental effect on the A549
cells.
With respect to M. tuberculosis H37RV, isoniazid
and metal-free 1,10-phenanthroline had the largest
calculated Selectivity Index (SI) values (Table 4).
Although metal-free 1 and its metal complexes had
considerably lower SI values they still fell within the
acceptable range ([ 10) (Nguta et al. 2015).
With the exception of AgBF4, the SI values for both
S. aureus and P. aeruginosa were very much lower
than those found for M. tuberculosis H37RV across the
range of test compounds (no value[ 10). Against the
fungus, C. albicans, metal-free 1,10-phenanthroline
returned an extremely large SI value (1742) and this
was followed by amphotericin B (143) and the simple
metal salt, AgBF4 (74). Metal-free 1 and its two Ag
?
complexes had SI values in the range 13–21, with the
Mn2? complex giving the lowest value (ca. 3).
Finally, it is noteworthy that the core structure of
ligand 1 is identical to that of the naturally occurring
marine alkaloid, ascididemin (Fig. 4), which is known
to display potent antimicrobial (Bhakuni and Rawat
2010; Lindsay et al. 1995) and antitumor (Delfourne
and Bastide 2003; Matsumoto et al. 2003) activity in
its metal-free form. It is interesting that metal-free 1
and ascididemin (Lindsay et al. 1995) were both
relatively inactive against Gram-negative P. aerugi-
nosa. Contrastingly, whereas the current synthetic
compounds are somewhat non-toxic towards human
lung epithelium A549 cells (CC50 = 157.23 lM)
these cells are quite intolerant of the pyridoacridine
alkaloid (IC50 = 0.02 lM) Delfourne and Bastide
2003).
Conclusions
Ligand 1 and its Ag? and Mn2? complexes are readily
obtained with robust yields from relatively cheap
starting materials. Ligand 1 is not susceptible to
immediate hydrolysis in presence of H2O over a
period of 7 days and the stability of the Ag?
complexes varies with the nature of the counterion.
The [Ag(1)2]NO3 complex shows signs of decompo-
sistion with 12 h in a DMSO solution, whereas the
[Ag(1)2]BF4 complex does not display instability in
similar conditions when tested over 3 days. The
activity displayed by ligand 1 is comparable to INH
towards M. tuberculosis H37RV with its Ag
? and
Mn2? complexes being four times more active. These
compounds are more selective towards M. tuberculo-
sis H37RV over mammalian A549 cells and display SI
vales[ 10. In addition, these compounds have very
good, broad-spectrum antimicrobial activity.
Fig. 4 Comparison of the core structures (shown in solid
bonds) of 1 and ascididemin
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Supplementary information
Crystallographic data, CCDC 1907353 can be
obtained free of charge from the Cambridge Crystal-
lographic Data Centre via www.ccdc.cam.ac.uk/data_
request/cif. Electronic supplementary material
available.
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